Cost-Effectiveness and Budget Impact of Cardioform versus Amplatzer and Medical Therapy Alone for Patent Foramen Ovale Closure: A UK Payer Perspective

Authors
Category Primary study
JournalClin. Outcomes Res.
Year 2026
This article has no abstract
Epistemonikos ID: 810d8960d5a873cb2014a789ea764833974fbbac
First added on: Oct 03, 2026